EXHIBIT 10.1 PORTIONS OF THIS EXHIBIT WERE OMITTED AND HAVE BEEN FILED SEPARATELY WITH THE SECRETARY OF THE COMMISSION PURSUANT TO THE COMPANY'S APPLICATION REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 24B-2 OF THE EXCHANGE ACT. COLLABORATION AND...Country Serial • February 1st, 2007 • Altus Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • New York
